newsfilter
← Latest News
GlobeNewswire·

Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment

PLUR
  • Pluri Inc. appointed Alejandro Weinstein as Chairman of the Board of Directors on Dec. 09, 2025.
  • Weinstein's ownership stake is expected to increase to approximately 30% on an issued and outstanding basis.
  • Mr. Zami Aberman transitioned from Chairman to Vice Chairman after serving for two decades.
  • Weinstein brings over 20 M&A transactions and more than $5 billion in exits across healthcare, biotechnology, & nutrition.
  • The Company entered a Securities Purchase Agreement to sell 625,000 common shares & warrants for up to 625,000 additional shares.
  • The private placement occurred at a combined price of $4 per share with an aggregate gross proceeds of approximately $2.5 million.
  • Warrants carry an exercise price of $4.25 per share, are exercisable immediately, & expire on June 30, 2026.
  • Proceeds from the transaction are intended for general working capital.
  • Weinstein previously transformed CFR Pharmaceuticals into a multinational group acquired by Abbott for $2.9 billion.
  • CEO Yaky Yanay stated the leadership change aims to sharpen execution, accelerate commercialization, & unlock asset value.